ClinicalTrials.govpublic full text
Galiximab in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
lymphoma, recurrent adult hodgkin lymphoma, adult lymphocyte predominant hodgkin lymphoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 982624
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.